HOUSE DOCKET, NO. 1844        FILED ON: 2/12/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1055

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Peter Capano

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to costs for treatment and management of diabetes.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Peter Capano

11th Essex

2/12/2021

David Henry Argosky LeBoeuf

17th Worcester

2/23/2021

Jessica Ann Giannino

16th Suffolk

6/14/2021

Elizabeth A. Malia

11th Suffolk

6/14/2021

Steven Ultrino

33rd Middlesex

6/14/2021

Lindsay N. Sabadosa

1st Hampshire

6/14/2021

Michael D. Brady

Second Plymouth and Bristol

6/14/2021

Steven C. Owens

29th Middlesex

6/14/2021

Mindy Domb

3rd Hampshire

6/15/2021

Patrick M. O'Connor

Plymouth and Norfolk

6/15/2021

Linda Dean Campbell

15th Essex

6/15/2021

Paul F. Tucker

7th Essex

6/16/2021

Danillo A. Sena

37th Middlesex

6/16/2021

Marcos A. Devers

16th Essex

7/16/2021

Jack Patrick Lewis

7th Middlesex

7/22/2021

Natalie M. Higgins

4th Worcester

7/22/2021

Michelle L. Ciccolo

15th Middlesex

7/27/2021


HOUSE DOCKET, NO. 1844        FILED ON: 2/12/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1055

By Mr. Capano of Lynn, a petition (accompanied by bill, House, No. 1055) of Peter Capano and David Henry Argosky LeBoeuf relative to costs for treatment and management of diabetes.  Financial Services.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act relative to costs for treatment and management of diabetes.

 

Whereas, The deferred operation of this act would tend to defeat its purpose, which is to establish forthwith limits on out-of-pocket costs for the treatment of diabetes, therefore it is hereby declared to be an emergency law, necessary for the immediate preservation of the public convenience.
 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 17G of chapter 32A of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 2. Section 10C of chapter 118E of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 3. Section 47N of chapter 175 of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 4. Section 8P of chapter 176A of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 5. Section 4S of chapter 176B of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.

SECTION 6. Section 4H of chapter 176G of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after the first sentence the following sentence:-

The deductible, copayment or coinsurance or other cost-sharing requirement shall not exceed: (1) $25 for a 30-day supply of insulin; (2) $50 for a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels; and (3) $100 for all other items described in this section.